标题
Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
作者
关键词
-
出版物
Biomed Research International
Volume 2014, Issue -, Pages 1-7
出版商
Hindawi Limited
发表日期
2014-07-18
DOI
10.1155/2014/965384
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells
- (2014) Masahiro Abe et al. STEM CELLS
- BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells
- (2013) Eun Hee Yi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells
- (2013) Aejaz Sayeed et al. PLoS One
- Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
- (2013) Takeshi Harada et al. PLoS One
- Antibody Therapeutics in Cancer
- (2013) M. X. Sliwkowski et al. SCIENCE
- Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function
- (2012) Y.-T. Tai et al. BLOOD
- Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
- (2012) Isabelle Herth et al. EXPERIMENTAL HEMATOLOGY
- Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer
- (2012) Takuhei Yokoyama et al. INTERNATIONAL JOURNAL OF CANCER
- Monoclonal antibodies in hematological malignancies: Past, present and future
- (2012) I Tazi et al. Journal of Cancer Research and Therapeutics
- Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- (2012) Sagar Lonial et al. JOURNAL OF CLINICAL ONCOLOGY
- Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
- (2012) A Ikegame et al. LEUKEMIA
- Anti-CD20 Antibody Therapy for B-Cell Lymphomas
- (2012) David G. Maloney NEW ENGLAND JOURNAL OF MEDICINE
- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
- (2011) F. Gay et al. BLOOD
- Characterization of a Transitional Preplasmablast Population in the Process of Human B Cell to Plasma Cell Differentiation
- (2011) Michel Jourdan et al. JOURNAL OF IMMUNOLOGY
- Lenalidomide Enhances Antigen-Specific Activity and Decreases CD45RA Expression of T Cells from Patients with Multiple Myeloma
- (2011) B. Neuber et al. JOURNAL OF IMMUNOLOGY
- Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study
- (2011) G S Nowakowski et al. LEUKEMIA
- Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma
- (2011) N W C J van de Donk et al. LEUKEMIA
- Host factors involved in retroviral budding and release
- (2011) Juan Martin-Serrano et al. NATURE REVIEWS MICROBIOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans
- (2011) E. Erikson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients
- (2010) Takahiro Ishiguro et al. CANCER SCIENCE
- Antigen-Dependent Internalization Is Related to Rapid Elimination from Plasma of Humanized Anti-HM1.24 Monoclonal Antibody
- (2010) J. Amano et al. DRUG METABOLISM AND DISPOSITION
- Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
- (2010) M. S. van der Veer et al. HAEMATOLOGICA
- Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells
- (2010) Wei Cao et al. IMMUNOLOGICAL REVIEWS
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- BST-2/tetherin: a new component of the innate immune response to enveloped viruses
- (2010) David T. Evans et al. TRENDS IN MICROBIOLOGY
- An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization
- (2009) M. Jourdan et al. BLOOD
- Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis
- (2009) Dongqing Cai et al. BMC CANCER
- A gene expression signature shared by human mature oocytes and embryonic stem cells
- (2009) Said Assou et al. BMC GENOMICS
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- HM1.24 Is Internalized from Lipid Rafts by Clathrin-mediated Endocytosis through Interaction with α-Adaptin
- (2009) Naoko Masuyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
- (2009) Wei Cao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Melan-A/MART1 Analog Peptide Triggers Anti-myeloma T-cells Through Crossreactivity With HM1.24
- (2009) Olaf Christensen et al. JOURNAL OF IMMUNOTHERAPY
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
- (2009) H Quach et al. LEUKEMIA
- HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody
- (2008) Wei Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interferon-α enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models
- (2008) Shigeto Kawai et al. CANCER SCIENCE
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
- Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells
- (2008) Wei Wang et al. LUNG CANCER
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
- (2008) Stuart J. D. Neil et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started